Endocrine Abstracts

The Purpose of The Research: The aim of the study is to reveal whether there are any peculiarities of treatment of the subacute thyroiditis, which was caused by Covid-19.

Materials and Methods: The research has been conducted in “Muratsan” Hospital Complex and Armenian-American Wellness Center during 2020-2021. Among forty five patients who participated in the study were women about 35+10 years old and all of them were diagnosed with subacute thyroiditis with various degrees of severity after Covid-19. All of them underwent a general blood test: TSH, FT4, ultrasound of the thyroid gland. A Glucocorticoid treatment was prescribed - Prednisolone 30-40 mg in ⅔ dose in the morning, ⅓ dose at 12:00-13:00pm. Afterwards, within 2-3 months the dose was gradually reduced and removed.

Results: After the withdrwal of the prescription the 22 (45%) out of the 45 patients had a recurrence of the disease, moreover 8 (36,4 %) of them had the recurrence of the disease 3-4 times. New inflammatory of the disease foci have appeared in the thyroid gland. As the Glucocorticoid treatment was not effective and 50% of them had recurrence, it was decided to add Arbidol to the treatment according to the following regimes: Arbidol 200 mg 1 piece x 2 for 5 days, 1 piece x 1 for 5 days. The results were unexpected. All the patients had stable remission.

Conclusion: In case of subacute thyroiditis caused by Covid-19, it is more preferable to add antiviral drugs to the Glucocorticoid treatment in order to avoid the recurrence. After the Covid-19 viremia persists in the blood and it may cause a subacute thyroiditis (6-8 weeks later).